RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections

Clinical trial NCT02733432 · COMPLETED

Trial details

NCT number: NCT02733432
Sponsor: Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Candidiasis, Vulvovaginal Mycoses Yeast Infection Moniliasis, Vulvovaginal Vaginitis, Monilial

Start date: 2016-06-08
Primary completion: 2016-11-23
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.